Erosive Esophagitis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis
BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Dec. 2, 2019-- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 2, 2019 Category: Pharmaceuticals Source Type: clinical trials
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: Vonoprazan; Drug: Lansoprazole Sponsor: Phathom Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2019 Category: Research Source Type: clinical trials
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis
Condition: Healed Erosive Esophagitis Interventions: Drug: Tegoprazan 25mg QD; Drug: Lansoprazole 15mg QD Sponsor: CJ HealthCare Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2019 Category: Research Source Type: clinical trials
